Pain Relief Repurposing, Hangover Drug
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
211
NCT02737397
Safety and Efficacy of a Combination Product for the Prevention of Veisalgia
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2016
Completion: May 31, 2016
NCT03183297
Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001
Phase: Phase 1
Start: Aug 31, 2017
Completion: Dec 31, 2017
NCT05007522
Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19
Phase: Phase 3
Start: May 3, 2022
Completion: Jun 20, 2024
Loading map...